The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment
- Resource Type
- Article
- Source
- In
Biomaterials May 2022 284 - Subject
- Language
- ISSN
- 0142-9612